My bookmarksSign up free
Source

Commission Implementing Regulation (EU) 2024/2048 of 29 July 2024 amending Implementing Regulation (EU) 2017/2470 as regards the specifications and the conditions of use of the novel food protein extract from pig kidneys

Commission Implementing Regulation (EU) 2024/2048 of 29 July 2024 amending Implementing Regulation (EU) 2017/2470 as regards the specifications and the conditions of use of the novel food protein extract from pig kidneys

Implementing Regulation (EU) 2024/2048 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

The Annex to Implementing Regulation (EU) 2017/2470 is amended in accordance with the Annex to this Regulation.

Article 2

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX The Annex to Implementing Regulation (EU) 2017/2470 is amended as follows: (1) in Table 1 (Authorised novel foods), the entry for ‘Protein extract from pig kidneys’ is replaced by the following: Authorised novel food Conditions under which the novel food may be used Additional specific labelling requirements Other requirements ‘ Protein extract from pig kidneys Specified food category Maximum levels     Food supplements as defined in Directive 2002/46/EC 12,6 mg protein extract from pig kidney/day containing 0,9 mg/day diamine oxidase (DAO) taken in 3 doses per day, each dose containing a maximum of 0,3 mg DAO Food for special medical purposes as defined in Regulation (EU) No 609/2013 In accordance with the particular nutritional requirements of the persons for whom the products are intended, but not higher than 12,6 mg protein extract from pig kidney/day containing 0,9 mg/day DAO’     (2) in Table 2 (Specifications), the entry for ‘Protein extract from pig kidneys’ is replaced by the following: Authorised novel food Specification ‘ Protein extract from pig kidneys Description/Definition: The protein extract is obtained from homogenised pig kidneys through a combination of salt precipitation and high-speed centrifugation. The obtained precipitate contains essentially proteins with 7 % of the enzyme diamine oxidase (enzyme nomenclature E.C. 1.4.3.22) and is resuspended in a physiologic buffer system. The obtained protein extract from pig kidney is formulated in appropriate forms and dosage to reach the active sites of digestion. Basic product: Specification: Protein extract from pig kidney with natural content of diamine oxidase (DAO): Physical condition: liquid Colour: brownish Appearance: slightly turbid solution pH value: 6,4-6,8 Enzymatic activity: > 2 677 kHDU DAO/ml (DAO REA (DAO Radio Extraction Assay)) Microbiological criteria: Brachyspira spp.: negative (Real Time PCR) Listeria monocytogenes : negative (Real Time PCR) Staphylococcus aureus : < 100 CFU/g Influenza A: negative (Reverse Transcription Real Time PCR) Escherichia coli : < 10 CFU/g Total aerobic microbiological count: < 10 5 CFU/g Yeasts/moulds count: < 10 5 CFU/g Salmonella : Absence/10 g Bile salt resistant enterobacteriaceae: < 10 4 CFU/g Final product: Specification protein extract from pig kidney with natural content of DAO (E.C. 1.4.3.22) in appropriate forms and dosage to reach the active sites of digestion: Physical condition: solid Colour: yellow grey Enzymatic activity: 110-220 kHDU DAO/g (DAO REA (DAO Radio Extraction Assay)) Acid stability 15 min 0,1M HCl followed by 60 min Borat pH = 9,0: > 68 kHDU DAO/g (DAO REA (DAO Radio Extraction Assay)) Humidity: < 10 % Microbiological criteria: Staphylococcus aureus : < 100 CFU/g Escherichia coli : < 10 CFU/g Total aerobic microbiological count: < 10 4 CFU/g Total combined yeasts/moulds count: < 10 3 CFU/g Salmonella : Absence/10 g Bile salt resistant enterobacteriaceae: < 10 2 CFU/g PCR: Polymerase Chain Reaction; HDU (Histamine Degrading Units) Description/Definition: The protein extract is obtained from homogenised pig kidneys through a series of steps involving a number of acetone washes to defat and dehydrate the homogenized pig kidneys, followed by draining, drying, milling, and sieving to produce a powder containing essentially proteins with a 7-9 % (on average) content of the enzyme diamine oxidase (enzyme nomenclature E.C. 1.4.3.22). The protein extract from pig kidney is formulated in appropriate forms and dosage to reach the active sites of digestion. Basic product: Specification: Protein extract from pig kidney with natural content of diamine oxidase (DAO): Physical condition: powder Colour: pale brown Enzymatic activity: ≥ 0,10 mU/mg (ultra-high performance liquid chromatography linked with fluorescent detection) Humidity: < 10 % Residual solvents: Acetone: < 5 000 mg/kg Microbiological criteria: Staphylococcus aureus : < 100 CFU/g Escherichia coli : < 10 CFU/g Total aerobic microbiological count: < 10 4 CFU/g Total combined yeasts/moulds count: < 10 3 CFU/g Salmonella : Absence/10 g Bile salt resistant enterobacteriaceae: < 10 2 CFU/g Listeria monocytogenes : absence in 25 g Final product: Specification protein extract from pig kidney with natural content of DAO (E.C. 1.4.3.22) in appropriate forms and dosage to reach the active sites of digestion: Physical condition: solid Colour: pale brown Enzymatic activity: 2,29-4,6 mU/g (ultra-high performance liquid chromatography linked with fluorescent detection). Acid stability 15 min 0,1M HCl followed by 60 min Borat pH = 9,0: > 1,4 mU DAO/g (ultra-high performance liquid chromatography linked with fluorescent detection) Humidity: < 10 % Microbiological criteria: Staphylococcus aureus : < 100 CFU/g Escherichia coli : < 10 CFU/g Total aerobic microbiological count: < 10 4 CFU/g Total combined yeasts/moulds count: < 10 3 CFU/g Salmonella : Absence/10 g Bile salt resistant enterobacteriaceae: < 10 2 CFU/g Listeria monocytogenes : absence in 25 g mU: milliUnit (expressed in mU/mg) measures nanomols (nmol) of histamine degraded by the DAO per minute using ultra-high performance liquid chromatography linked with fluorescent fetection (O. Comas-Basté et al. Analytical and Bioanalytical Chemistry 411:7595-7602 (2019)). 1 mU corresponds to 48 000 HDU of the DAO Radio Extraction Assay (REA) method.’

Other acts of the same type
Commission Implementing Regulation (EU) 2024/2464 of 12 September 2024 concerning the authorisation of pine white essential oil from Pinus pinaster Aiton as a feed additive for all animal speciesCommission Implementing Regulation (EU) 2024/2434 of 11 September 2024 derogating in respect of the year 2024 from Article 44(2), second subparagraph, of Regulation (EU) 2021/2116 of the European Parliament and of the Council as regards the level of advance payments for interventions in the form of direct payments and area-based and animal-based rural development interventionsCommission Implementing Regulation (EU) 2024/2445 of 11 September 2024 derogating in respect of the year 2024 from Article 75(1), third subparagraph, of Regulation (EU) No 1306/2013 of the European Parliament and of the Council as regards the level of advance payments for area-related and animal-related rural development measuresCommission Implementing Regulation (EU) 2024/2391 of 10 September 2024 amending Implementing Regulation (EU) 2017/1185 as regards certain reporting requirements, certain notifications to the Commission of information, and documents in the agricultural markets sectorCommission Implementing Regulation (EU) 2024/2392 of 10 September 2024 amending Implementing Regulation (EU) 2022/191 imposing a definitive anti-dumping duty on imports of certain iron or steel fasteners originating in the People’s Republic of China following acceptance of a request for new exporting producer treatmentCommission Implementing Regulation (EU) 2024/2465 of 10 September 2024 amending Regulations concerning restrictive measures and setting out a single list for the Annexes to those Regulations containing the contact details of Member States’ competent authorities and the address for notifications to the European CommissionCouncil Regulation (EU) 2024/2591 of 10 September 2024 on the allocation of fishing opportunities under the Protocol on the implementation of the Fisheries Partnership Agreement between the European Community and the Republic of Guinea-Bissau (2024–2029)Commission Implementing Regulation (EU) 2024/2382 of 9 September 2024 amending Implementing Regulation (EU) 2022/1195 as regards the template for the surveys of Synchytrium endobioticum (Schilbersky) Percival, the designation of infested production sites and the revocation of measures in infested areasCommission Implementing Regulation (EU) 2024/2384 of 9 September 2024 initiating a review of an exempted party pursuant to Regulation (EC) No 88/97 and making the imports of the exempted party subject to registrationCommission Implementing Regulation (EU) 2024/2385 of 9 September 2024 concerning the authorisation of 4-methyl-5-vinylthiazole as a feed additive for all animal speciesCommission Implementing Regulation (EU) 2024/2389 of 9 September 2024 concerning the authorisation of a preparation of semduramicin sodium (Aviax 5 %) as a feed additive for chickens for fattening (holder of authorisation: Phibro Animal Health s.a.) and repealing Regulation (EC) No 1443/2006Commission Implementing Regulation (EU) 2024/2393 of 9 September 2024 concerning the renewal of the authorisation of sodium bisulphate and the authorisation of new uses of that substance as a feed additive for certain animal species

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next